A study of psychological pain in substance use disorder and its relationship to treatment outcome
Autoři:
Steven Mee aff001; Blynn G. Bunney aff002; Ken Fujimoto aff003; John Penner aff001; Garrett Seward aff001; Keeley Crowfoot aff001; William E. Bunney aff002; Christopher Reist aff002
Působiště autorů:
Applied Innovative Psychiatry, Los Alamitos, California, United States of America
aff001; Department of Psychiatry, University of California Irvine, Irvine, California, United States of America
aff002; Loyola University, Chicago, IIlinois, United States of America
aff003
Vyšlo v časopise:
PLoS ONE 14(11)
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pone.0216266
Souhrn
Substance Use Disorder (SUD) is a major public health concern affecting an estimated 22.5 million individuals in the United States. The primary aim of this study was to characterize psychological pain in a cohort of patients participating in outpatient treatment for SUD. A secondary aim was to determine the relationships between pre-treatment assessments of psychological pain, depression, anxiety and hopelessness with treatment retention time and completion rates. Data was analyzed from 289 patients enrolled in an outpatient community drug treatment clinic in Southern California, U.S. A previously determined threshold score on the Mee-Bunney Psychological Pain Assessment Scale (MBP) was utilized to group patients into high and low-moderate scoring subgroups. The higher pain group scored higher on measures of anxiety, hopelessness and depression compared to those in the low-moderate pain group. Additionally, patients scoring in the higher psychological pain group exhibited reduced retention times in treatment and more than two-fold increased odds of dropout relative to patients with lower pre-treatment levels of psychological pain. Among all assessments, the correlation between psychological pain and treatment retention time was strongest. To our knowledge, this is the first study to demonstrate that psychological pain is an important construct which correlates with relevant clinical outcomes in SUD. Furthermore, pre-treatment screening for psychological pain may help target higher-risk patients for clinical interventions aimed at improving treatment retention and completion rates.
Klíčová slova:
Anxiety – Depression – Drug therapy – Emotions – Charts – Outpatients – Pain psychology – Suicide
Zdroje
1. SAMSHA. Behavioral Health Baraometer. Substance Abuse and Mental Health Administration [Internet]. 2015. Available from: http://store.samhsa.gov/shin/content//SMA16-BARO-2015/SMA16-BARO-2015.pdf.
2. CDC. Drug Overdose Deaths. 2018.
3. US Surgeon General R. Facing Addiction in America. Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Reports of the Surgeon General. Washington (DC)2016.
4. NIDA. Principles of Drug AddictionTreatment: A Research-Based Guide (Third Edition). 2018.
5. Deane FP, Wootton DJ, Hsu CI, Kelly PJ. Predicting dropout in the first 3 months of 12-step residential drug and alcohol treatment in an Australian sample. J Stud Alcohol Drugs. 2012;73(2):216–25. doi: 10.15288/jsad.2012.73.216 22333329.
6. NIDA. Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). 2012.
7. Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev. 2013;33(8):1010–24. doi: 10.1016/j.cpr.2013.07.007 24029221.
8. Decker KP, Peglow SL, Samples CR, Cunningham TD. Long-Term Outcomes After Residential Substance Use Treatment: Relapse, Morbidity, and Mortality. Mil Med. 2017;182(1):e1589–e95. doi: 10.7205/MILMED-D-15-00560 28051978.
9. Stahler GJ, Mennis J, DuCette JP. Residential and outpatient treatment completion for substance use disorders in the U.S.: Moderation analysis by demographics and drug of choice. Addict Behav. 2016;58:129–35. doi: 10.1016/j.addbeh.2016.02.030 26925821.
10. Stark MJ. Dropping out of substance abuse treatment: A clinically oriented review. Clin Psychol Rev. 1992;12(1):93–116.
11. Reist C, Mee S, Fujimoto K, Rajani V, Bunney WE, Bunney BG. Assessment of psychological pain in suicidal veterans. PLoS One. 2017;12(5):e0177974. doi: 10.1371/journal.pone.0177974 28558020.
12. Mee S, Bunney BG, Bunney WE, Hetrick W, Potkin SG, Reist C. Assessment of psychological pain in major depressive episodes. J Psychiatr Res. 2011;45(11):1504–10. doi: 10.1016/j.jpsychires.2011.06.011 21831397.
13. Patterson AA, Holden RR. Psychache and suicide ideation among men who are homeless: a test of Shneidman's model. Suicide Life Threat Behav. 2012;42(2):147–56. doi: 10.1111/j.1943-278X.2011.00078.x 22324750.
14. Troister T, Holden RR. A two-year prospective study of psychache and its relationship to suicidality among high-risk undergraduates. J Clin Psychol. 2012;68(9):1019–27. doi: 10.1002/jclp.21869 22644790.
15. Soumani A, Damigos D, Oulis P, Masdrakis V, Ploumpidis D, Mavreas V, et al. Mental pain and suicide risk: application of the Greek version of the Mental Pain and the Tolerance of Mental Pain scale. Psychiatriki. 2011;22(4):330–40. 22271846.
16. Leenaars AA. Lives and deaths: Biographical notes on selections from the works of Edwin S. Shneidman. Suicide Life Threat Behav. 2010;40(5):476–91. doi: 10.1521/suli.2010.40.5.476 21034210.
17. Pompili M, Lester D, Leenaars AA, Tatarelli R, Girardi P. Psychache and suicide: a preliminary investigation. Suicide Life Threat Behav. 2008;38(1):116–21. doi: 10.1521/suli.2008.38.1.116 18355113.
18. Orbach I. Mental pain and suicide. Isr J Psychiatry Relat Sci. 2003;40(3):191–201. 14619678.
19. Berlim MT, Mattevi BS, Pavanello DP, Caldieraro MA, Fleck MP, Wingate LR, et al. Psychache and suicidality in adult mood disordered outpatients in Brazil. Suicide Life Threat Behav. 2003;33(3):242–8. 14582835.
20. Orbach I, Mikulincer M, Gilboa-Schechtman E, Sirota P. Mental pain and its relationship to suicidality and life meaning. Suicide Life Threat Behav. 2003;33(3):231–41. 14582834.
21. Meerwijk EL, Ford JM, Weiss SJ. Suicidal crises because of diminishing tolerance to psychological pain. Brain Imaging Behav. 2013;7(3):245–7. doi: 10.1007/s11682-013-9234-3 23640703.
22. Conejero I, Olie E, Calati R, Ducasse D, Courtet P. Psychological Pain, Depression, and Suicide: Recent Evidences and Future Directions. Curr Psychiatry Rep. 2018;20(5):33. doi: 10.1007/s11920-018-0893-z 29623441.
23. Shneidman ES. Suicide as psychache. J Nerv Ment Dis. 1993;181(3):145–7. doi: 10.1097/00005053-199303000-00001 8445372.
24. Meerwijk EL, Weiss SJ. Toward a unifying definition: response to 'The concept of mental pain'. Psychother Psychosom. 2014;83(1):62–3. doi: 10.1159/000348869 24281693.
25. Guimaraes R, Fleming M, Cardoso MF. Validation of the Orbach & Mikulincer Mental Pain Scale (OMMP) on a drug addicted population. Soc Psychiatry Psychiatr Epidemiol. 2014;49(3):405–15. doi: 10.1007/s00127-013-0751-6 23995521.
26. Andersson HW, Steinsbekk A, Walderhaug E, Otterholt E, Nordfjaern T. Predictors of Dropout From Inpatient Substance Use Treatment: A Prospective Cohort Study. Subst Abuse. 2018;12:1178221818760551. doi: 10.1177/1178221818760551 29531472; PubMed Central PMCID: PMC5843095.
27. Koob GF. The dark side of emotion: the addiction perspective. Eur J Pharmacol. 2015;753:73–87. doi: 10.1016/j.ejphar.2014.11.044 25583178; PubMed Central PMCID: PMC4380644.
28. Linehan M, Addis M. Screening for sucidal behaviors: the suicidal behaviors questionnaire 1990.
29. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67(3):588–97. doi: 10.1207/s15327752jpa6703_13 8991972.
30. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974;42(6):861–5. doi: 10.1037/h0037562 4436473.
31. Beck ATE N.; Brown G.; Steer R.A. An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893–897. Journal of Consulting and Clinical Psychology. 1988;56:893–7.
32. SAMHSA. Treatment Episode Data Sets (TEDS). 2016.
33. Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg. 2010;126(6):2234–42. doi: 10.1097/PRS.0b013e3181f44abc 20697313; PubMed Central PMCID: PMC2998589.
Článek vyšel v časopise
PLOS One
2019 Číslo 11
- Jak a kdy u celiakie začíná reakce na lepek? Možnou odpověď poodkryla čerstvá kanadská studie
- Pomůže v budoucnu s triáží na pohotovostech umělá inteligence?
- Spermie, vajíčka a mozky – „jednohubky“ z výzkumu 2024/38
- Skotská studie upřesnila zdravotní benefity aktivního cestování za prací a studiem
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
Nejčtenější v tomto čísle
- A daily diary study on maladaptive daydreaming, mind wandering, and sleep disturbances: Examining within-person and between-persons relations
- A 3’ UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction
- A substitution mutation in a conserved domain of mammalian acetate-dependent acetyl CoA synthetase 2 results in destabilized protein and impaired HIF-2 signaling
- Molecular validation of clinical Pantoea isolates identified by MALDI-TOF
Zvyšte si kvalifikaci online z pohodlí domova
Všechny kurzy